What is the TNM (Tumor, Node, Metastasis) staging for adenocarcinoma of the lung?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TNM Staging for Lung Adenocarcinoma

Lung adenocarcinoma staging follows the 8th edition IASLC/AJCC TNM classification system, which provides more granular T-stage subdivisions based on 1-cm tumor size increments and refined M-stage categories based on the number and location of metastatic sites. 1

T Stage (Primary Tumor)

The T descriptor is determined by tumor size, location, and invasion of adjacent structures 1:

Size-Based Classification

  • Tis (AIS): Adenocarcinoma in situ 1
  • T1mi: Minimally invasive adenocarcinoma ≤3 cm with ≤0.5 cm invasion 1
  • T1a: Tumors ≤1 cm 1
  • T1b: Tumors >1 cm to 2 cm 1
  • T1c: Tumors >2 cm to 3 cm 1
  • T2a: Tumors >3 cm to 4 cm 1
  • T2b: Tumors >4 cm to 5 cm 1
  • T3: Tumors >5 cm to 7 cm 1
  • T4: Tumors >7 cm 1

Critical Measurement Rule for Part-Solid Tumors

For part-solid adenocarcinomas, measure only the solid (invasive) component for T-stage assignment, though the total tumor size including ground-glass opacity should also be recorded. 1 This represents a major change from prior editions and provides better prognostic discrimination 2.

Additional T2 Features (regardless of size)

  • Endobronchial tumor involving main bronchus at any distance from carina (without carinal involvement) 1
  • Atelectasis or obstructive pneumonitis extending to the hilum 1
  • Visceral pleural invasion 1

T3 Features

  • Invasion of chest wall, phrenic nerve, parietal pleura, or pericardium 1
  • Ipsilateral satellite nodule in the same lobe as primary tumor 1

T4 Features

  • Invasion of carina, diaphragm, vertebral body, mediastinum, heart, trachea, esophagus, or recurrent laryngeal nerve 1
  • Ipsilateral satellite nodules in a different lobe from primary tumor 1

N Stage (Regional Lymph Nodes)

The N stage is based on anatomic location of metastatic lymph nodes 1:

  • N0: No regional lymph node metastases 1
  • N1: Metastasis in ipsilateral peribronchial and/or hilar lymph nodes, including involvement by direct extension 1
  • N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes 1
  • N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes 1

Lymph nodes >10 mm in short-axis diameter are considered abnormal, with 30% prevalence of metastasis for nodes 10-15 mm and 67% for nodes >15 mm. 1

M Stage (Distant Metastasis)

The 8th edition subdivides metastatic disease based on number and location 1, 3:

  • M0: No distant metastasis 1
  • M1a: Separate tumor nodule(s) in contralateral lobe; pleural or pericardial nodules; malignant pleural or pericardial effusion 1
  • M1b: Single extrathoracic metastasis in a single organ 1, 3
  • M1c: Multiple extrathoracic metastases in one or several organs 1, 3

Stage Grouping

The complete stage grouping according to the 8th edition 1:

Early Stages

  • Stage 0: Tis, N0, M0 1
  • Stage IA1: T1a(mi)/T1a, N0, M0 1
  • Stage IA2: T1b, N0, M0 1
  • Stage IA3: T1c, N0, M0 1
  • Stage IB: T2a, N0, M0 1
  • Stage IIA: T2b, N0, M0 1

Locally Advanced Stages

  • Stage IIB: T1a-c/T2a-b, N1, M0 or T3, N0, M0 1
  • Stage IIIA: T1a-c/T2a-b, N2, M0 or T3, N1, M0 or T4, N0-1, M0 1
  • Stage IIIB: T1a-c/T2a-b, N3, M0 or T3-4, N2, M0 1
  • Stage IIIC: T3-4, N3, M0 1

Metastatic Stages

  • Stage IVA: Any T, Any N, M1a or M1b 3
  • Stage IVB: Any T, Any N, M1c 3

Special Considerations and Pitfalls

Multiple Ground-Glass Nodules

Multiple synchronous ground-glass or part-solid nodules representing adenocarcinoma in situ, minimally invasive adenocarcinoma, or lepidic-predominant adenocarcinoma should be classified as separate primary lung cancers, not intrapulmonary metastases. 1 Stage according to the highest T category with the number of lesions indicated in parentheses 1.

Pneumonic-Type Adenocarcinoma

For invasive mucinous adenocarcinoma presenting with consolidation: T-stage based on size if single lesion, T3 if entire lobe involved, T4 if multiple ipsilateral lobes, M1a if bilateral involvement 1.

Common Staging Pitfalls

  • Do not use total tumor size for part-solid lesions—only the solid component determines T-stage 1
  • Lymph node size alone is insufficient—histologic or cytologic confirmation required for nodes 10-15 mm before denying surgery 1
  • Diaphragmatic invasion is now T4, not T3 as in prior editions 1
  • Endobronchial location is now T2a regardless of distance from carina (as long as carina not involved) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.